REG - Iofina PLC - Q1 2024 Corporate Update

IofinaAnnouncement

16/04/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240416:nRSP7098Ka&default-theme=true

RNS Number : 7098K  Iofina PLC  16 April 2024

16 April 2024

 

Iofina plc

("Iofina", the "Company" or the "Group")

(AIM: IOF)

 

Q1 2024 Corporate Update

IO#10 on Track

Renewal of Iodide Rich Brine Water Supply Agreements

 

Iofina plc, specialists in the exploration and production of iodine and
manufacturers of specialty chemical products, today provides a brief update to
the market regarding its activities during Q1 2024 (the "Period").

 

The Company continued to perform as expected during the Period, with Iofina
Resources producing 123.7 metric tonnes ('MT') of crystalline iodine from its
six IOsorb® iodine plants in Oklahoma. This was an increase of 15.5% from Q1
2023 (107.1 MT). Demand for Iofina's iodine remained strong throughout the
Period and was supported by a further expansion in the customer base. The
iodine spot price has remained steady in the mid to upper sixties per kg and
prices are expected to remain at these levels in Q2 2024. The Company's sales
channels remain robust, which is encouraging as it executes its production
expansion plans.

 

Iofina's newest build, IO#10, is on track and progressing well. Dirt and
concrete work are complete. Major components have been ordered, including the
tower system which was sourced from an additional manufacturer to ensure ample
supply from multiple vendors. The final steps for completion will focus on the
tower installation, assembling buildings, plumbing, electricals and tying into
our partner's brine system, which will happen during the early summer months.
The Company continues to work on other growth projects and is in advanced
dialogue with multiple partners for the next plant, IO#11.

 

 

Additionally, Iofina has signed new multi-year agreements for the supply of
brine water to two of Iofina Resources' current IOsorb® plants. The new
agreed terms, with one of Iofina's existing oil & gas partners, is an
important milestone in maintaining consistent iodine production at both
plants, whilst enabling our partners to maximise the supply of brine to these
plants. The expectation remains that Iofina Resources will produce 275-295 MT
of crystalline iodine during H1 2024 from its six existing plants (H1 2023:
241.5 MT). Iofina recognises that previous brine water supply fees for these
two plants were lower than the standard market rates due to the historical
nature of the contracts. Consequently, the new contracts carry higher fees
than the previous agreements. The higher fee payments, which are effective 1
January 2024, will reduce EBITDA, and the Board expects FY 2024 EBITDA to be
in the range of $8.5-$9.0 million.

 

On the current timetable, IO#10 should make a healthy additional contribution
for the H2 period and once operating, IO#10 is expected to produce 100-150MT
of crystalline iodine per annum. The Company notes that it expects to publish
its 2023 full-year financial results to the market in the coming weeks and
hold its AGM in June 2024.

 

Commenting, President and CEO, Dr. Tom Becker, stated:

"The Group has made a strong start to the year across its operations. We have
experienced consistent iodine production with output meeting our targeted
range and demand for our products continues to be strong. The construction of
IO#10 is also on track and is expected to be completed in Q3 2024 on the
current trajectory.

 

"It is important to have signed new agreements with our partner and secured
future water supply to two IOsorb® plants. Guaranteeing this security means
that Iofina can continue its future growth plans with confidence in our
partners and focus on the development of new plants and products."

 

This announcement contains inside information for the purposes of article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by
virtue of the European Union (Withdrawal) Act 2018.

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Nomad & Broker:

Henry Fitzgerald-O'Connor/Harry Rees

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

 

Media Contact:

Charles Goodwin/Shivantha Thambirajah

Yellow Jersey PR Limited

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated company that specialises in
the production of Iodine and the manufacturing of specialty chemical products.
Iofina is the second largest producer of iodine in North America and operates
the manufacturing entities Iofina Resources and Iofina Chemical.

 

LEI: 213800QDMFYVRJYYTQ84

 

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns, and operates iodine extraction plants
using Iofina's WET® IOsorb® technology. Iofina currently operates five
producing IOsorb® plants in Oklahoma and is consistently using technology and
innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen speciality chemicals
derived from raw iodine, as well as non-iodine-based products.  Iofina
Chemical celebrated its 40(th) anniversary in 2023 as a preeminent
halogen-based specialty chemicals company.

 

www.iofina.com (http://www.iofina.com/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDFFFSISVIELIS